Objective: Atrial fibrillation is the most common arrhythmia after cardiac surgery. Amiodarone
can effectively prevent and control postoperative atrial and ventricular fibrillation. Acute …

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …

Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …

In April 2002, an 83-year-old woman was admitted in emergency with an 8-hour history of
dyspnea and palpitations. The patient referred a diagnosis of cardiomyopathy 6 months …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Non–islet cell tumor hypoglycemia is usually associated with large, welldifferentiated tumors
commonly of mesenchymal origin (1). Hypoglycemia is due to tumor production of pro …

Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Amiodarone is a class III antiarrhythmic agent with a long half-life which is used to control
atrial and ventricular arrhythmias, including atrial flutter and fibrillation. We describe here the …

Anticholesterol, cardiovascular, and endocrine drugs and hormonal agents present a wide
range of hepatotoxicity. If there is a common thread among these agents, it relates to their …